The pharmaceutical and healthcare packaging sector has reached a defining moment. Packaging formats such as blister packs, bottles, tubes, pouches, sachets, cartons and protective wraps are indispensable for ensuring sterility, dose accuracy and patient safety. Yet, once used, the overwhelming majority of this packaging follows a linear trajectory towards disposal or destruction.

This linearity now stands in direct conflict with regulatory, environmental and societal expectations. Under the EU Green Deal, pharmaceutical packaging is no longer viewed as an exceptional category insulated from sustainability obligations. Instead, it is increasingly scrutinised as part of the broader packaging waste system – subject to Extended Producer Responsibility (EPR), recycled content expectations, and net-zero healthcare ambitions.

Despite this shift, recycling rates remain alarmingly low. Estimates suggest that only around 14% of blister packs – enter any form of dedicated recycling stream.1 For many other primary and secondary pharmaceutical packaging formats, effective recycling pathways barely exist. Most materials are still incinerated or landfilled, often by regulatory default rather than by design.

The question facing the industry is no longer whether pharmaceutical packaging must become circular, but how this can be achieved without compromising safety, compliance or performance.

Why Pharmaceutical Packaging Has Been Left Behind

Pharmaceutical packaging sits at the intersection of some of the most complex requirements in the packaging world.

This starts with material complexity. Blister packs combine aluminium with multi-layer polymers. Tubes and pouches rely on laminated structures, adhesives and barrier layers. Bottles, closures and dispensers may incorporate pigments, additives and functional components to meet regulatory and performance standards.